Loading...

Loading...

The Week In Health: Clinic Expansion, AI Governance, Chronic Care
The Week In Health: Clinic Expansion, AI Governance, Chronic Care
By Sergio Arturo Lievano Madrigal - Thu, 08/27/2026 - 15:22
This week: Mexico opens hiring for 12,750 new clinics, while the General Health Council made cardio-renal-metabolic care protocols mandatory.
https://mexicobusiness.news/tag/obesity
More Health
Mexico Makes Cardio-Renal-Metabolic Care Protocols Mandatory
Mexico Makes Cardio-Renal-Metabolic Care Protocols Mandatory
By Sergio Arturo Lievano Madrigal - Tue, 08/25/2026 - 09:00
CSG makes cardio-renal-metabolic PRONAM mandatory for Mexico's public health institutions, with 90 days to file implementation plans starting Aug. 25.
The Week In Health: Hospital Investment, Obesity Care
The Week In Health: Hospital Investment, Obesity Care
By Sergio Arturo Lievano Madrigal - Thu, 07/30/2026 - 16:31
This week, ISSSTE expands clinics, COFEPRIS advances trial reform, and AI reshapes oncology and digital health. This and more in the weekly roundup.

Global Growth Fuels Boehringer Ingelheim's Mexico Bet
Global Growth Fuels Boehringer Ingelheim's Mexico Bet
By Sergio Arturo Lievano Madrigal - Thu, 07/30/2026 - 12:56
Boehringer Ingelheim's 16.2% 1H26 sales growth coincides with a 22% rise in its Mexico clinical research investment for the year.
Why Pharma's Next Advantage Will Be Predictive Intelligence
Why Pharma's Next Advantage Will Be Predictive Intelligence
By María Jesús Salido Rojo - Tue, 07/28/2026 - 05:00
AI and digital twins can transform GLP-1 obesity care by predicting trajectories and personalizing patient outcomes, writes María Jesús Salido.
Innovation, Medical Education Needed to Reshape Obesity Treatment
Innovation, Medical Education Needed to Reshape Obesity Treatment
By Sergio Arturo Lievano Madrigal - Mon, 07/27/2026 - 12:28
Treating obesity early is vital to preventing a secondary cascade of related chronic illnesses, says Novo Nordisk’s Patricia Field.
FDA Approves Merck Oral Pill for High Cholesterol
FDA Approves Merck Oral Pill for High Cholesterol
By Sergio Arturo Lievano Madrigal - Mon, 07/20/2026 - 12:03
FDA approves Merck's Lipfendra, the first oral PCSK9 pill for high cholesterol, as Mexico's pharma sector expands cardiovascular care.
Financing Gap, Obesity Push, EU Deal Define Health This Week
Financing Gap, Obesity Push, EU Deal Define Health This Week
By Sergio Arturo Lievano Madrigal - Fri, 07/17/2026 - 13:47
This week: out-of-pocket spending jumps 41%, obesity policy advances on multiple fronts, and the EU deal boosts medical device exports.
Mexico's Obesity Response Becomes a Business Inflection Point
Mexico's Obesity Response Becomes a Business Inflection Point
By Sergio Arturo Lievano Madrigal - Thu, 07/16/2026 - 16:51
While Mexico's obesity response is advancing across several tracks simultaneously, many companies are already adjusting their investment strategy.

PAHO Advances Anti-Obesity Push With School Health Guidelines
PAHO Advances Anti-Obesity Push With School Health Guidelines
By Sergio Arturo Lievano Madrigal - Thu, 07/16/2026 - 09:22
PAHO and OAS unveil new school health guidelines and officials push for policy action, as Mexico City hosts the International Congress on Obesity.
From Reactive to Predictive: What the Gut Microbiome Reveals
From Reactive to Predictive: What the Gut Microbiome Reveals
By Gustavo Rodríguez Leal - Wed, 07/08/2026 - 08:30
Mexico’s precision medicine must target the gut microbiome to prevent chronic diseases like obesity and diabetes, writes Gustavo Rodríguez.